Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period 1	STARTED	Zetomipzomib First, Then Placebo (Arm A)	13
Treatment Period 1	STARTED	Placebo First, Then Zetomipzomib (Arm B)	12
Treatment Period 1	COMPLETED	Zetomipzomib First, Then Placebo (Arm A)	10
Treatment Period 1	COMPLETED	Placebo First, Then Zetomipzomib (Arm B)	12
Treatment Period 1	NOT COMPLETED	Zetomipzomib First, Then Placebo (Arm A)	3
Treatment Period 1	NOT COMPLETED	Placebo First, Then Zetomipzomib (Arm B)	0
Treatment Period 2	STARTED	Zetomipzomib First, Then Placebo (Arm A)	10
Treatment Period 2	STARTED	Placebo First, Then Zetomipzomib (Arm B)	12
Treatment Period 2	COMPLETED	Zetomipzomib First, Then Placebo (Arm A)	8
Treatment Period 2	COMPLETED	Placebo First, Then Zetomipzomib (Arm B)	12
Treatment Period 2	NOT COMPLETED	Zetomipzomib First, Then Placebo (Arm A)	2
Treatment Period 2	NOT COMPLETED	Placebo First, Then Zetomipzomib (Arm B)	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04033926/flow